Results 201 to 210 of about 79,488 (241)

Targeting the MYCN interaction network in neuroblastoma. [PDF]

Biosci Rep
Yow CX, Yeoh S, Leen E, Bayliss R.
europepmc   +1 more source

MYC-driven TRIM27 upregulation promotes prostate cancer progression by enhancing CANX ubiquitination and activating PI3K/AKT signaling. [PDF]

Funct Integr Genomics
Wang Z, Ning J, Xu L, Cheng F.
europepmc   +1 more source

Identification and characterization of genomic target sites for MLL fusion proteins [PDF]

, 2006
Lehmbacher, Michael
core  

POM121 O-GlcNAcylation facilitates bone metastasis in non-small cell lung cancer through enhanced c-MYC nuclear import and ECM reprogramming. [PDF]

Oncogene
Ren YZ, Zhao MN, Du FL, Wu L, Wang L, Lou JT.   +5 more
europepmc   +1 more source

Integrative Machine Learning and Experimental Validation Identify MYBL2 as a Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma. [PDF]

Oncol Res
Yang YL, Huang YH, Lin HY.
europepmc   +1 more source

A novel regulatory role of microRNA‑5590‑3p in hepatocellular carcinoma via the HOXB2/MYC axis. [PDF]

Oncol Rep
Li B, Zhou L.
europepmc   +1 more source

miRNA‑29a inhibits the proliferation of HUVECs by regulating the ITGB1/β‑catenin/c‑Myc pathway. [PDF]

Mol Med Rep
Sun Q, Chen W, Zhang S, Zhong X, Wu Y, Qian Y, Zhu L, Zhang T, Li W.   +8 more
europepmc   +1 more source

Hsa_circ_0003611 hinders the transformation of mesenchymal stem cells into osteosarcoma cells through suppressing MYC by IGF2BP3 via m⁶A modification. [PDF]

Biol Res
Zhang F, Cheng F, He Z, Zhao C.
europepmc   +1 more source

Extrachromosomal DNA in Solid Tumors-Landscape, Immune Effects, and Resistance to Targeted Therapy. [PDF]

Oncol Res
Badran O, Attarya S.
europepmc   +1 more source

MST4 plays dual roles in lung adenocarcinoma by regulating homeostasis of wild-type and mutant p53 protein. [PDF]

Oncogene
Zhang M, Hu C, Liu H, Zhang C, Shu Q, Kang YJ, Ding Y, Zhang J, Hu Z, Wang H, Zhang Y, Zhang ZY, Li S.   +12 more
europepmc   +1 more source